BTA 0.00% 57.0¢ biota holdings limited

Quoting Portable Alpha “Management have done a great job...

  1. 830 Posts.
    Quoting Portable Alpha “Management have done a great job developing the pipeline.”

    I let the half-year results speak for Peter Idiot:
    From page 6 of the results:
    EXPENSES:
    Research and development expenses were $6,339 (2007: $4,656) reflect the development on partnered and other projects. UP 36%
    Product development expenses were $6,022 (2007: $5,928), consistent with the advancement of our clinical programs, particularly HRV, LANI and RSV. UP 3%

    REVENUE:
    Research revenue of $4,210 (2007: $4,915) represents fee for services provided as a result of the AstraZeneca and Boehringer Ingelheim collaboration agreements; DOWN 15%
    Milestone payments of $NIL (2007: $3,419); DOWN 100%

    Portable Alpha, Peter Cook is the most useless CEO you can ever find – a PROVEN failure as the CEO of OEC and a total parasite at BTA. Peter Cook is doing such a great job developing the pipeline that research revenue is down 15% and the Milestone payment has dropped to ZERO despite R&D development expenses going up 36%. It is no wonder you are impressed with Peter Cook refusing a $100m settlement offer and then after spending $30m in legal fees sold it for $20m.





 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.